Condition: Dyspnea
Intervention:
Sponsor: Deep Breeze
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
Condition: Asthma Patients
Interventions: Drug: AZD1981; Drug: AZD1981; Drug: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma
Condition: Asthma
Interventions: Drug: Budesonide; Drug: Budesonide; Drug: Budesonide
Sponsor: Activaero GmbH
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Repeat Dose Safety Study for Compound to Treat Asthma
Condition: Asthma
Interventions: Drug: 1440115; Drug: Placebo
Sponsor: Octagon Research Solutions, Inc.
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients
Condition: Asthma
Interventions: Drug: Formoterol/Fluticasone; Drug: Foraseq®; Drug: Fluticasone
Sponsor: Eurofarma Laboratorios Ltda
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients With Asthma
Condition: Asthma
Interventions: Drug: Salmeterol/Fluticasone; Drug: Seretide
Sponsor: Eurofarma Laboratorios Ltda
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Condition: Persistent Allergic Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsors: Novartis; Genentech
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Effect of Allergen Challenge on Inflammation Induced by Toll-like Receptor Stimulation in a Nasal Model
Condition: Asthma
Interventions: Other: Nasal allergen challenge; Other: Nasal placebo challenge
Sponsor: McMaster University
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula
Condition: Allergy and Asthma
Intervention:
Sponsor: Mead Johnson Nutrition
Completed – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
QTc Study With Flucticasone Furoate & GW642444
Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Interventions: Drug: Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination; Drug: Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination; Drug: Placebo Inhaler; Drug: Moxifloxacin 400mg; Drug: Moxifloxacin placebo
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days